Michela Buscarino
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Cancer Research and Treatments, HER2/EGFR in Cancer Research, Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer
Most-Cited Works
- → Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer(2012)1,867 cited
- → Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients(2015)1,079 cited
- → A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer(2011)941 cited
- → Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer(2015)403 cited
- → The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets(2015)305 cited
- → Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer(2014)268 cited
- → Erratum: Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients(2015)259 cited
- → Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer(2016)206 cited
- → Inhibition of MEK and PI3K/mTOR Suppresses Tumor Growth but Does Not Cause Tumor Regression in Patient-Derived Xenografts of RAS-Mutant Colorectal Carcinomas(2012)193 cited
- → Increased Detection Sensitivity for KRAS Mutations Enhances the Prediction of Anti-EGFR Monoclonal Antibody Resistance in Metastatic Colorectal Cancer(2011)158 cited